[Antiviral potentials. Preliminary note].
D000547:Amantadine / Q000494:pharmacology; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects; D004668:Encephalitis Viruses / Q000032:analysis / Q000187:drug effects; D005227:Fatty Acids / Q000032:analysis; D005467:Floxuridine / Q000494:pharmacology; D008049:Lipase / Q000494:pharmacology; D008055:Lipids / Q000032:analysis / Q000494:pharmacology*; D009975:Orthomyxoviridae / Q000032:analysis / Q000187:drug effects; D010743:Phospholipids / Q000032:analysis; D011212:Poxviridae / Q000032:analysis / Q000187:drug effects; D011925:Rauscher Virus / Q000032:analysis / Q000187:drug effects; D012190:Retroviridae / Q000032:analysis; D013882:Thiosemicarbazones / Q000494:pharmacology
D000998:Antiviral Agents; D005227:Fatty Acids; D008055:Lipids; D010743:Phospholipids; D013882:Thiosemicarbazones; D005467:Floxuridine; D000547:Amantadine; D008049:Lipase
Potenziali antivirali. Nota preliminare.